MICHELLE BIGG: Open Payments
NPI 1033781471 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 30 payments from 8 companies in 2025. Trend: 2023 $465 · 2024 $264 · 2025 $1,521
Long term medical supply or device loan: $897Food & beverage: $525Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $1,056 |
| Daiichi Sankyo Inc. | 5 | $155 |
| AstraZeneca Pharmaceuticals LP | 2 | $151 |
| Janssen Biotech, Inc. | 2 | $54 |
| SOBI, INC | 1 | $37 |
| BeOne Medicines USA, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| ARRAY BIOPHARMA INC | 1 | $14 |
Products named: KISQALI, Enhertu, Fabhalta, TALVEY, Doptelet, BRUKINSA, DATROWAY, JEMPERLI.
Industry payments across NV — which companies pay providers there.
